The opioid epidemic: is pharma doing enough to develop treatments for the crisis?

Pharmaceutical Technology | May 30, 2022

Even with academic collaborations, private players are lagging behind public institutions in finding new treatments for opioid addiction. Marco Pravetoni, PhD, is currently working on developing a potential vaccine aimed at oxycodone, which is in Phase I trials, and aims to get vaccines targeting other drugs like fentanyl or heroin into the clinic in the coming years.


Final report: Improving Washingtonians’ resilience and recovery from traumatic events with a Trauma-Informed Care ECHO Clinic

Department news | April 30, 2022

Through our Innovation Grants Program launched in 2020, we allocated nearly $1 million to a terrific set of diverse proposals from faculty, staff and trainees on a wide range of topics. Kristen Lindgren, PhD, ABPP and Michele Bedard-Gilligan, PhD, completed their project called “Improving Washingtonians’ resilience and recovery from traumatic events with a Trauma-Informed Care […]


Final report: Opioid prescription and use following traumatic brain injury

Department news | April 30, 2022

Through our Innovation Grants Program launched in 2020, we allocated nearly $1 million to a terrific set of diverse proposals from faculty, staff and trainees on a wide range of topics. Amy Starosta, PhD, Jeanne Hoffman, PhD, and Kari Stephens, PhD, completed their project called “Opioid Use following Traumatic Brain Injury”. Individuals with Traumatic brain […]


Inside the Seattle lecture room where experts are brainstorming the future of psychedelic research

The Seattle Times | April 23, 2022

Scientists, doctors, advocacy workers, and other community members gathered to discuss the next frontier of treating substance-use disorders and addiction: psychedelics. The meeting was convened by the Center for Novel Therapeutics in Addiction Psychiatry led by Nathan Sackett, MD and was sponsored, in part, by the Garvey Institute for Brain Health Solutions.




New ECHO program will support care of people with TBI

Department news | December 28, 2021

The ECHO (Extension for Community Healthcare Outcomes) model uses a virtual educational lecture series and patient case discussion to improve provider preparedness to treat patients and improve patient outcomes. Our department has successfully used the model to expand the mental health and addictions care in our state and currently has ECHO programs in perinatal psychiatry, […]



Can magic mushrooms help ease anxiety and depression?

Right as Rain | November 15, 2021

Microdosing psilocybin has become trendy among people hoping to alleviate anxiety or increase creativity. Nathan Sackett, MD, talks about its promise as a therapeutic agent and his plans to build a novel therapeutics research program that will explore the pairing of compounds like psilocybin and ketamine with behavioral interventions to treat addictions.